A systematic review of single-dose aminoglycoside therapy for urinary tract infection: Is it time to resurrect an old strategy?
Conclusions: Single-dose aminoglycoside therapy appears to be an effective treatment option for lower UTI in non-septic patients, with minimal toxicity. Additional studies would be beneficial to confirm efficacy for pyelonephritis. When resistance to first-line UTI agents is endemic, aminoglycosides may serve as β-lactam and fluoroquinolone-sparing options.
PMID: 30397061 [PubMed - as supplied by publisher]
Source: Antimicrobial Agents and Chemotherapy - Category: Microbiology Authors: Goodlet KJ, Benhalima FZ, Nailor MD Tags: Antimicrob Agents Chemother Source Type: research
More News: Antibiotic Therapy | Chemotherapy | Cystitis | Databases & Libraries | Endemics | Gastroenteritis | Microbiology | Pyelonephritis | Radiography | Study | Toxicology | Urinary Tract Infections